Hostile competition among the biotechnology & pharmaceutical companies, the emergence of novel drug and to gain market advantage from first to market strategy are the prime drivers for the clinical trial management system (CTMS) market.

Chicago, IL -- (SBWire) -- 02/22/2017 --According to the new market research report, "Clinical Trial Management System (CTMS) Market, by Components (Software, Service), Delivery Modes (Web-based, On-premises, Cloud-based), Types (Enterprises, Site), End-users (Pharmaceutical and Biotechnology Companies, Clinical Research Organization, Medical Device Companies) Global Revenue, Trends, Growth, Share, Size and Forecast to 2022", published by Scalar Market Research, the global clinical trial management system (CTMS) market is expected to grow at a healthy CAGR of 14.30% from 2016 to 2022. At the expected CAGR, the clinical trial management system (CTMS) market is expected to grow from USD 1.32 billion in 2016 and reach USD 2.95 billion in 2022.

The global clinical trial management system (CTMS) market report offers in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key players, premium insights, technology trends and forecast to 2022. It also focuses on the key drivers and opportunities in this market.

Request Sample: https://www.scalarmarketresearch.com/request-sample.php?id=221

Buyers will receive 10% customization on this report.

Key findings of the report:

- Global clinical trial management system (CTMS) market is expected to be driven by the strong competition among the pharmaceutical and biotechnology companies and the rapid emergence of the novel drugs.

- The growth in the competition to implement the first-to-market strategy among the key players is also anticipated to be one of the major drivers for the clinical trial management system (CTMS) market during the forecast period.

- The growing competition to gain market advantage through the first-to-market strategy is also one of the primary drivers for the clinical trial management system (CTMS) market.

In-depth segmentation analysis of the clinical trial management system (CTMS) market

The report provides detailed analysis of the market segmentation for CTMS. The report broadly segments the clinical trial management system market by components, delivery modes, types, end-users, and the major geographic regions. The component segment of the market is further divided into services and software. The delivery mode segment is further divided into on-premise, web-based, and cloud-based clinical trial management systems.

Browse Report Summary: https://www.scalarmarketresearch.com/market-reports/clinical-trial-management-system-ctms-market

The type segment of the market is further divided into site CTMS and enterprise CTMS. The report further divides the end-user segment into clinical research organizations, pharmaceutical and biotechnology companies, and medical device companies. The clinical trial management system (CTMS) market is segmented across four geographic regions, which include North America, Europe, Asia-Pacific, and Rest of the World.

Key Benefits of the Report:

- The report offers thorough quantitative analysis of the current and future market trends to showcase the revenue caliber of the clinical trial management system (CTMS) market

- The report offers in-depth analysis of the key drivers and restraints affecting the global market during the next few years

- The report provides clear understanding of the roles of the key players and stakeholders involved in the clinical trial management system (CTMS) market

Key Topics Covered:

-Market Overview
-Executive Summary
-Market Dynamics
-Industry Analysis
-Clinical Trial Management System (CTMS) Market, By Components
-Clinical Trial Management System (CTMS) Market, By Delivery Modes
-Clinical Trial Management System (CTMS) Market, By Types
-Clinical Trial Management System (CTMS) Market, By End-Users
-Clinical Trial Management System (CTMS) Market, By Geography
-Competitive Landscape

Key Market Players:

PAREXEL International Corporation
Medidata Solutions, Inc.
Bio-Optronics, Inc.
Bioclinica.
Merge Healthcare Incorporated
ERT Clinical
eClinForce, Inc.
DATATRAK International Inc.
DSG, Inc.
Veeva Systems

Browse Related Reports:

In-Vitro Diagnostics (IVD) Market, by Products (Instruments & Systems and Reagents & Consumables Segments), Applications (Immunochemistry, Clinical Chemistry, Hematology, Infectious Disease, Microbiology, Genetic Testing, and Histology & Cytology) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2021
https://www.scalarmarketresearch.com/market-reports/in-vitro-diagnostics-ivd-market

Orphan Drugs Market, by Indication Types (Oncology, Ophthalmology, Hematology, Cardiovascular, Neurology, and Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022
https://www.scalarmarketresearch.com/market-reports/orphan-drugs-market

About Scalar Market Research
Scalar Market Research, Inc. is a Chicago, U.S.-based market research and consulting firm that serves Fortune 1000 companies, leading businesses and upcoming organizations from around the world to help them achieve their business goal of sustainable revenue growth, utilizing Scalar's premium market research reports and consulting services to make critical strategic decisions.

Our real-time industry data tracking, with the help of advanced analytics and machine learning, offers our clients highly accurate 360-degreeperspective of key developments in niche markets. Our team of industry experts, with a thorough understanding of the global markets and cumulative industry experience spanning 100+ years, works relentlessly to help our clients realize their most important business goals.

Find out more about our services at: http://www.scalarmarketresearch.com

Contact:
Moses Nakka
8770 W Bryn Mawr Ave.,
Suite 1300
Chicago, IL 60631
Tel.: +1-800-213-5170 (U.S./Canada Toll-free)
Email: sales@scalarmarketresearch.com
Follow us on LinkedIn: https://www.linkedin.com/company/scalar-market-research